Clinical Outcomes of Recurrent Intracranial Meningiomas Treated with Proton Beam Reirradiation.
11/05/2019
/
Publications
/
Reirradiation
Toxicity
Survival
This is a retrospective analysis of 16 patients who received PBRT reRT for recurrent meningiomas. The median PBRT dose was 60 Gy(RBE) and the median follow-up...
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
11/08/2019
/
Publications
/
Pencil Beam Scanning - PBS
Toxicity
This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...
A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
11/07/2019
/
Publications
/
Toxicity
Reirradiation
Sixty-nine patients with sinonasal tumors underwent curative intent PBT including 42 patients received de novo irradiation and 27 received reirradiation. With...
Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
11/11/2019
/
Publications
/
Toxicity
Hepatocellular carcinoma (HCC) with inferior vena cava tumor thrombus (IVCTT) is rare and regarded as an advanced disease stage with a poor prognosis. This...
Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
11/11/2019
/
Publications
/
Toxicity
Survival
Chemotherapy
This study from Taiwan retrospectively examined 30 patients with unresectable CC who were treated with PBT to a total dose of 72.6 GyRBE. The 1-year local...
The role of proton therapy in pediatric malignancies: Recent advances and future directions.
03/02/2020
/
Publications
/
Toxicity
This systematic review provides latest outcomes data after proton therapy across the common pediatric disease sites.
It discusses the main attempts to assess...
Proton beam therapy for liver cancers.
03/02/2020
/
Publications
/
Dosimetry
Toxicity
A review article examined the latest utilization of PBT for hepatocellular carcinoma and cholangiocarcinoma, as well as liver metastasis. The dosimetric...
Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies.
05/07/2020
/
Publications
/
Toxicity
Reirradiation
IMPT
Published in Seminar Radiation Oncology, this review article evaluated clinical data up-to-date on proton reirradiation for local and regional recurrence. As...
Proton Beam Therapy Is a Safe and Effective Treatment in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESCC).
05/06/2020
/
Publications
/
Toxicity
Survival
This study from Japan reported results of 54 esophageal cancer patients who are over 75 years old treated with PBT. 38 inoperable patients (70.4%) and 16...
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
28/04/2020
/
Publications
/
Hypofractionation
Survival
Toxicity
Published by the NCC group in Korea, this study reported outcomes of 45 patients including 37 had recurrent and/or residual disease treated with PBT to a total...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.